Mumps Clinical Trials Mumps RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Condition:   Epidemic Parotitis,Mumps Interventions:   Biological: ≥3.0 lgCCID50/mlbut ＜3.5lgCCID50/ml Live Attenuated Mumps Vaccine (Human Diploid Cell) in infants(8-24 months old);   Biological: ≥4.5 lgCCID50/ml Live Attenuated Mumps Vaccine (Human Diploid Cell) in infants(8-24 months old);   Biological: Measles and Mumps Combined Vaccine， Live(SIBP)( positive control) Sponsors:   Chinese Academy of Medical Sciences;   Hubei Provincial Center for Disease Control and Prevention Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2017 Category: Research Source Type: clinical trials